David W Ollila MD
Breast, Melanoma, Surgical Oncology (Other than Breast)
James and Jesse Millis Distinguished Professor of Surgery, Co-Leader UNC Multidisciplinary Melanoma and Complex Skin Cancer Program, University of North Carolina at Chapel Hill School of Medicine
Join to View Full Profile
170 Manning DriveChapel Hill, NC 27599
Phone+1 919-966-5221
Fax+1 919-966-8806
Dr. Ollila is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Saint John’s Cancer Institute/Providence Saint John’s Health CenterFellowship, Complex General Surgical Oncology, 1995 - 1998
OhioHealth/Riverside Methodist HospitalResidency, Surgery, 1990 - 1995
University of Cincinnati College of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1995 - Present
NC State Medical License 1998 - 2025
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery Start of enrollment: 2002 May 01
- Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer Start of enrollment: 2012 Jul 01
- Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma Start of enrollment: 2019 Dec 17
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- The Landmark Series: Melanoma and Adjuvant Therapy.Michael C Lowe, Keith A Delman, David W Ollila
Annals of Surgical Oncology. 2025-03-11 - Association of inherited genetic variants with multiple primary melanoma.David C Gibbs, Brittany M Small, Isidora Autuori, Siok F Leong, Emily Ali
Cancer Epidemiology, Biomarkers & Prevention. 2025-03-04 - Outcomes and Trends in Axillary Management of Stage cN3b Breast Cancer Patients.Julia M Selfridge, Zachary Schrank, Chris B Agala, David W Ollila, Kristalyn K Gallagher
Annals of Surgical Oncology. 2025-03-01
Journal Articles
- The Changing Paradigms for Breast Cancer Surgery: Performing Fewer and Less-Invasive OperationsDavid R Brenin, E Shelley Hwang, Katharine Yao, David W Ollila, Henry M Kuerer, Annals of Surgical Oncology
Press Mentions
2019 Oncology Excellence Awards Celebrate Compassionate Nurses and StaffOctober 8th, 2019- Melanoma Symposium to Include Talks on Treatment, NutritionMarch 11th, 2019
How Effective Is Talimogene Laherparepvec Injection in Metastatic Melanoma?February 1st, 2019
Grant Support
- Immunotherapy With A Polyvalent Melanoma Vaccine PLUS BCG In Stage IVNational Center For Research Resources2004–2006
- Active Immunotherapy With A Polyvalent Melanoma Vaccine In Stage IIINational Center For Research Resources2004–2006
- Immunotherapy W/ Melanoma Vaccine PLUS BCG In MelanomaNational Center For Research Resources2000
- Active Immunotherapy W/ BCG &Melanoma Vaccine, CancervaNational Center For Research Resources2000
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
